| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 88892-83-5 | 1-(2,5-Dimethylphenyl)-5-thioxo-2-pyrrolidinone | C12H13NOS |
| 88892-84-6 | 1-(2,4-Dimethylphenyl)-3-thioxo-2,5-pyrrolidinedione | C12H11NO2S |
| 88892-89-1 | 1-(6-Methyl-5H-[1,2,4]triazolo[4,3-b][1,2,4]triazol-5-yl)ethanone | C6H7N5O |
| 88894-02-4 | [(2Z)-2-(1-Ethylnaphtho[1,2-d][1,3]thiazol-2(1H)-ylidene)ethylidene]malononitrile | C18H13N3S |
| 88894-91-1 | Bovine growth hormone-releasing factor 1-44 amide | C220H366N72O66S |
| 88898-17-3 | Atrial Natriuretic Factor (1-28) (Rat) | C128H205N45O39S2 |
| 88899-00-7 | 5-Amino-3-(2-deoxy-alpha-D-erythro-pentofuranosyl)imidazo[4,5-d][1,3]oxazin-7(3H)-one | C10H12N4O5 |
| 88899-15-4 | N-3-Cyclopenten-1-yl-L-alanine | C8H13NO2 |
| 88899-22-3 | Bz-Phe-Val-Arg-Amc | C37H43N7O6 |
| 88899-55-2 | Bafilomycin A1 | C35H58O9 |
| 88899-56-3 | Setamycin | C44H65NO13 |
| 88899-59-6 | 4-[(2-Hydroxyethyl)amino]-6-[(1R,2S,4aR,8aR)-2-methyl-1,2,4a,5,6,7,8,8a-octahydro-1-naphthalenyl]-2-oxo-2H-pyran-3-carbaldehyde | C19H25NO4 |
| 88899-60-9 | 2-Amino-7-fluoro-9H-fluoren-9-ol | C13H10FNO |
| 88899-61-0 | 4-Methoxy-6-[(1R,2S,4aR,8aR)-2-methyl-1,2,4a,5,6,7,8,8a-octahydro-1-naphthalenyl]-2-oxo-2H-pyran-3-carbaldehyde | C18H22O4 |
| 88899-62-1 | (1S,12aR,12bS)-1,2,12a,12b-Tetrahydro-1,4,9,12a-tetrahydroxy-3,10-Perylenedione | C20H14O6 |
| 88899-70-1 | 6-Methyl-2-nitrosopyrido[3',2':4,5]imidazo[1,2-a]pyridine | C11H8N4O |
| 88901-36-4 | Mogroside V | C60H102O29 |
| 88901-37-5 | Mogroside III-E | C48H82O19 |
| 88901-38-6 | Mogroside II-E | C42H72O14 |
| 88901-39-7 | Mogroside I-E1 | C36H62O9 |
| 88901-41-1 | Mogroside IV-A | C54H92O24 |
| 88901-42-2 | Mogroside III-A1 | C48H82O19 |
| 88901-43-3 | Mogroside III-A2 | C48H82O19 |
| 88901-44-4 | Mogroside II-A1 | C42H72O14 |
| 88901-45-5 | Mogroside II-A2 | C42H72O14 |
| 88901-46-6 | Mogroside I-A1 | C36H62O9 |
| 88901-69-3 | (5S,6R,7R,8R)-4,4',5,6,6',7,8-Heptahydroxy-2,2'-dimethoxy-7,7'-dimethyl-5,6,7,8-tetrahydro-1,1'-bianthracene-9,9',10,10'-tetrone | C32H26O13 |
| 88903-69-9 | Xestospongin C | C28H50N2O2 |
| 88903-92-8 | (6R)-6-(Dimethylamino)-5,6,7,8-tetrahydro-2,3-naphthalenediol | C12H17NO2 |
| 88903-93-9 | (6S)-6-(Dimethylamino)-5,6,7,8-tetrahydro-2,3-naphthalenediol | C12H17NO2 |
| 88905-76-4 | 4-Chloro-1,2,5-Thiadiazol-3-Ol | C2HClN2OS |
| 88907-48-6 | Bafilomycin B2 | C45H67NO13 |
| 88907-86-2 | (1R,5S)-1,2,5-Trimethyl-2-cyclopentene-1-carboxylic acid | C9H14O2 |
| 88908-15-0 | N-[(1-Methylhydrazino)carbonyl]-L-alanine | C5H11N3O3 |
| 88908-87-6 | Methyl 2-methylenebicyclo[3.1.0]hexane-1-carboxylate | C9H12O2 |
| 88909-82-4 | 9,10-Dihydro-1-Benzo[a]Pyrene-7(8H)-One Oxime | C20H15NO |
| 88909-96-0 | 4-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)butanoic acid | C16H13NO4 |
| 88912-21-4 | 6-Chloro-4-methoxypyridine-2-carboxylic acid | C7H6ClNO3 |
| 88912-23-6 | 2,6-Difluoro-4-pyridinecarboxylic acid | C6H3F2NO2 |
| 88912-24-7 | 5,6-Dichloro-2-pyridinecarboxylic acid | C6H3Cl2NO2 |
| 88912-25-8 | 4,6-Dichloro-2-pyridinecarboxylic acid | C6H3Cl2NO2 |
| 88912-26-9 | 2,5-Dichloroisonicotinic acid | C6H3Cl2NO2 |
| 88912-27-0 | 3-Chloroisonicotinic acid | C6H4ClNO2 |
| 88912-57-6 | N-{4-[(3E)-3-(2-Amino-4-oxo-1,5-dihydro-6(4H)-pteridinylidene)-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl]benzoyl}-L-glutamic acid | C23H21N7O7 |
| 88914-38-9 | N-{3-(Dimethylamino)-4-[(3-fluoro-5-methyl-9-acridinyl)amino]phenyl}methanesulfonamide | C23H23FN4O2S |
| 88914-39-0 | N-{4-[(3-Chloro-5-methyl-9-acridinyl)amino]-3-(dimethylamino)phenyl}methanesulfonamide | C23H23ClN4O2S |
| 88914-40-3 | N-{4-[(3-Chloro-5-methoxy-9-acridinyl)amino]-3-(dimethylamino)phenyl}methanesulfonamide | C23H23ClN4O3S |
| 88914-42-5 | N-{3-(Dimethylamino)-4-[(3-methoxy-5-methyl-9-acridinyl)amino]phenyl}methanesulfonamide | C24H26N4O3S |
| 88914-43-6 | N-{4-[(4,5-Dimethyl-9-acridinyl)amino]-3-(dimethylamino)phenyl}methanesulfonamide | C24H26N4O2S |
| 88914-44-7 | N-{4-[(4,5-Dimethoxy-9-acridinyl)amino]-3-(dimethylamino)phenyl}methanesulfonamide | C24H26N4O4S |